JO KOEPSEL: Open Payments
NPI 1104885086 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,883 in 187 payments from 18 companies in 2025. Trend: 2023 $3,199 · 2024 $3,784 · 2025 $3,883
Food & beverage: $3,771Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 23 | $603 |
| Supernus Pharmaceuticals, Inc. | 35 | $444 |
| Alkermes, Inc. | 26 | $412 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $405 |
| Corium, LLC | 21 | $381 |
| Vanda Pharmaceuticals Inc. | 14 | $279 |
| Neurocrine BioSciences, Inc. | 12 | $277 |
| Collegium Pharmaceutical, Inc. | 7 | $242 |
| Otsuka America Pharmaceutical, Inc. | 4 | $173 |
| E.R. Squibb & Sons, L.L.C. | 10 | $161 |
Products named: ARISTADA, CAPLYTA, Azstarys, Qelbree, FANAPT, AUSTEDO XR, Jornay PM, INGREZZA.
Industry payments across TX — which companies pay providers there.
